Clinical trial
Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic…
NCT00112528 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00112528 |
|---|---|
| Title | Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer |
| Official title | Phase II Trial of Bevacizumab, Gemcitabine, Oxaliplatin in Patients With Metastatic Pancreatic Adenocarcinoma |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Biological, Drug |
| Interventions | bevacizumab, gemcitabine hydrochloride, oxaliplatin |
| Enrollment | 53 |
| Start date | Jun 1, 2005 |
| Primary completion | Aug 1, 2006 |
| Completion | Nov 1, 2010 |
| First posted | Jun 3, 2005 |
| Last update posted | Dec 13, 2016 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: